Quarterly profit at Eli Lilly beats expectations

25 April, 2017

Higher than expected demand for its new products, Trulicity used in the treatment of diabetes and and Taltz prescribed for psoriasis led to a strong quarter of volume driven growth according to David Ricks their new chief executive.

For more on this story..